BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34410883)

  • 1. Comparative Impact of Depressive Symptoms and FEV
    O'Toole J; Woo H; Putcha N; Cooper CB; Woodruff P; Kanner RE; Paine R; Bowler RP; Comellas A; Hoth KF; Krishnan JA; Han M; Dransfield M; Iyer AS; Couper D; Peters SP; Criner G; Kim V; Barr RG; Martinez FJ; Hansel NN; Eakin MN;
    Ann Am Thorac Soc; 2022 Feb; 19(2):171-178. PubMed ID: 34410883
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
    Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
    J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, risk factors, and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan.
    Lin CW; Chen YY; Chen YJ; Liang CY; Lin MS; Chen W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1493-500. PubMed ID: 26251589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.
    Paulin LM; Gassett AJ; Alexis NE; Kirwa K; Kanner RE; Peters S; Krishnan JA; Paine R; Dransfield M; Woodruff PG; Cooper CB; Barr RG; Comellas AP; Pirozzi CS; Han M; Hoffman EA; Martinez FJ; Woo H; Peng RD; Fawzy A; Putcha N; Breysse PN; Kaufman JD; Hansel NN;
    JAMA Intern Med; 2020 Jan; 180(1):106-115. PubMed ID: 31816012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Poor Short-Term Prognosis and Unmet Needs in Advanced Chronic Obstructive Pulmonary Disease: Use of the Two-Minute Walking Distance Extracted from a Six-Minute Walk Test.
    Neo HY; Xu HY; Wu HY; Hum A
    J Palliat Med; 2017 Aug; 20(8):821-828. PubMed ID: 28353374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Esterman AJ; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012347. PubMed ID: 30838649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study.
    Lou P; Zhu Y; Chen P; Zhang P; Yu J; Zhang N; Chen N; Zhang L; Wu H; Zhao J
    BMC Pulm Med; 2012 Sep; 12():53. PubMed ID: 22958576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.
    Hansen JE; Dilektasli AG; Porszasz J; Stringer WW; Pak Y; Rossiter HB; Casaburi R
    Ann Am Thorac Soc; 2019 Dec; 16(12):1504-1517. PubMed ID: 31404502
    [No Abstract]   [Full Text] [Related]  

  • 10. Anxiety and depression among dairy farmers: the impact of COPD.
    Guillien A; Laurent L; Soumagne T; Puyraveau M; Laplante JJ; Andujar P; Annesi-Maesano I; Roche N; Degano B; Dalphin JC
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1-9. PubMed ID: 29296078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Male Subjects With Moderate COPD Based on Maximum Mid-Expiratory Flow.
    Aktan R; Ozalevli S; Alpaydin AO
    Respir Care; 2021 Mar; 66(3):442-448. PubMed ID: 32900916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of pulmonary rehabilitation on chronic obstructive pulmonary disease patients with concurrent presence of comorbid depression and anxiety.
    Yohannes AM; Casaburi R; Dryden S; Hanania NA
    Respir Med; 2022 Jun; 197():106850. PubMed ID: 35427843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parameter D: New Measure of Airflow Obstruction.
    Bhatt SP; Nakhmani A; Thimmegowda NM; Sthanam V; Wilson CG; Bhakta NR; Kim YI; Bodduluri S
    Ann Am Thorac Soc; 2023 Jul; 20(7):993-1002. PubMed ID: 36989246
    [No Abstract]   [Full Text] [Related]  

  • 14. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial.
    Donohue JF; Bollu VK; Stull DE; Nelson LM; Williams VS; Stensland MD; Hanania NA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():499-508. PubMed ID: 29440887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifaceted associations between walking performance, physical fitness, extremity function, health status, and depression in individuals with COPD.
    Aldhahi MI; Baattaiah BA; Alharbi MD; Alotaibi M; Nazer R; Albarrati A
    Ann Med; 2024 Dec; 56(1):2338248. PubMed ID: 38590164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidimensional outcome assessment of pulmonary rehabilitation in traits-based clusters of COPD patients.
    Augustin IML; Franssen FME; Houben-Wilke S; Janssen DJA; Gaffron S; Pennings HJ; Smeenk FWJM; Pieters WR; Hoogerwerf A; Michels AJ; van Merode F; Wouters EFM; Spruit MA
    PLoS One; 2022; 17(2):e0263657. PubMed ID: 35176055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study.
    Miravitlles M; Worth H; Soler Cataluña JJ; Price D; De Benedetto F; Roche N; Godtfredsen NS; van der Molen T; Löfdahl CG; Padullés L; Ribera A
    Respir Res; 2014 Oct; 15(1):122. PubMed ID: 25331383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between objectively measured physical activity and morning symptoms in COPD.
    van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
    Tan M; Jian W; Liang Q; Li S; Cui H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.